Skip to content

The Evaluation of Inflammatory Activity in Rheumatoid Arthritis by Using Fludeoxyglucose (18F)

The Evaluation of Inflammatory Activity in Rheumatoid Arthritis by Using Fludeoxyglucose (18F) - The Evaluation of RA activity by FDG-PET

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000000716
Enrollment
30
Registered
2007-05-11
Start date
2007-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

None listed

Sponsors

Department of Allergy and Rheumatology and Department of Radiology, University of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: active RA patient who fulfills all the criteria below: 1) diagnosed with RA by ACR criteria revised in 1987 2) more than 20 years old and who is able to self-judge 3) fully informed about this study and voluntarily consented for the enrollment 4) judged to be well-suited by the principal investigator or subinvestigator

Exclusion criteria

Exclusion criteria: patient who fulfills one of the following criteria must be excluded: 1) coexistence of arthropathy other than RA 2) complicated by clinically apparent infection or vasculitis 3) blood glucose more than 150mg/dL at the administration of 18F-FDG 4) under administration of infusion which contains glucose, or on insulin treatment 5) female patient during pregnancy or lactation 6) contraindicated for MRI 7) contraindicated for contrast-material infusion in MRI 8) judged to be inappropriate by the principal investigator or subinvestigator

Design outcomes

Primary

MeasureTime frame
The clinical evaluation of RA (physical examination and laboratory data), the findings of synovitis in hand MRI with contrast, and the SUV in FDG-PET (adjusted by weighting at each joint)

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026